MILGAMMA protekt film-coated tablets, 60 pcs

Instructions for use for MILGAMMA protekt film-coated tablets, 60 pcs

Milgamma Protekt is a medicinal product that is available without a doctor's prescription. It contains the active substance benfotiamine, a fat-soluble precursor of vitamin B1. Milgamma Protekt is used to treat neuropathies and cardiovascular disorders caused by a deficiency of vitamin B1. It can also be used for the therapy or prophylaxis of clinical vitamin B1 deficiencies if these cannot be corrected by diet. The recommended dosage for Milgamma Protekt is: 1 tablet per day, regardless of the meal. The duration of use depends on the symptoms and the course of the disease and should be determined in consultation with a doctor. In the treatment of nerve disorders caused by vitamin B1 deficiency, the medicine should be used for at least 3 weeks at the beginning. Milgamma Protekt is well tolerated and can relieve tingling, burning and numbness. Possible side effects include hypersensitivity, hives, skin rash, gastrointestinal discomfort and nausea. A doctor or pharmacist should be consulted if any symptoms occur during treatment. The medicinal product is contraindicated in case of hypersensitivity to the ingredients. In case of pregnancy and breast-feeding, a doctor or pharmacist should be consulted before use. Interactions with other medicines may occur, so medicines already in use should be stated before treatment. Milgamma Protekt comes in the form of film-coated tablets and contains 300 mg benfotiamine per tablet. Other ingredients are cellulose, microcrystalline, talc, povidone K30, silicon dioxide, highly dispersed, croscarmellose sodium, partial glycerides, long chain, hypromellose, titanium dioxide, macrogol and saccharin sodium. It is important to note that the information in the summary does not replace the package leaflet and that the package leaflet should be read before using Milgamma Protekt.